According to Izvestia, disulfiram reduces the risk of death from a new coronavirus infection.

It clarifies that the drug has reduced the number of COVID-19 cases by 34%.

According to the chief researcher of the Research Laboratory of Computer Modeling of Medicines.

V.A.

Potemkina SUSU Maria Grishina, the drug reduces the production of an enzyme that is involved in the metabolism of ethanol.

Thus, it can ease the symptoms of severe coronavirus by suppressing a protein involved in hyperinflammation.

Earlier, scientists from the Siberian State Medical University with colleagues from the Tomsk Research and Development Center established that inhalation of a gas mixture based on xenon can be used to treat respiratory failure in case of lung damage after COVID-19.